344 related articles for article (PubMed ID: 28919308)
1. Alternative splicing in cancers: From aberrant regulation to new therapeutics.
Song X; Zeng Z; Wei H; Wang Z
Semin Cell Dev Biol; 2018 Mar; 75():13-22. PubMed ID: 28919308
[TBL] [Abstract][Full Text] [Related]
2. Splicing-factor alterations in cancers.
Anczuków O; Krainer AR
RNA; 2016 Sep; 22(9):1285-301. PubMed ID: 27530828
[TBL] [Abstract][Full Text] [Related]
3. RNA in cancer.
Goodall GJ; Wickramasinghe VO
Nat Rev Cancer; 2021 Jan; 21(1):22-36. PubMed ID: 33082563
[TBL] [Abstract][Full Text] [Related]
4. The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations.
Malakar P; Shukla S; Mondal M; Kar RK; Siddiqui JA
RNA Biol; 2024 Jan; 21(1):1-20. PubMed ID: 38017665
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies.
Zhang F; Zhang L; Zhang C
Tumour Biol; 2016 Jan; 37(1):163-75. PubMed ID: 26586396
[TBL] [Abstract][Full Text] [Related]
6. MALAT1 long non-coding RNA in cancer.
Yoshimoto R; Mayeda A; Yoshida M; Nakagawa S
Biochim Biophys Acta; 2016 Jan; 1859(1):192-9. PubMed ID: 26434412
[TBL] [Abstract][Full Text] [Related]
7. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
Urbanski LM; Leclair N; Anczuków O
Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
[TBL] [Abstract][Full Text] [Related]
8. The oncogenic and tumor suppressive roles of RNA-binding proteins in human cancers.
Bitaraf A; Razmara E; Bakhshinejad B; Yousefi H; Vatanmakanian M; Garshasbi M; Cho WC; Babashah S
J Cell Physiol; 2021 Sep; 236(9):6200-6224. PubMed ID: 33559213
[TBL] [Abstract][Full Text] [Related]
9. Regulatory mechanisms of long noncoding RNAs on gene expression in cancers.
Sun W; Yang Y; Xu C; Guo J
Cancer Genet; 2017 Oct; 216-217():105-110. PubMed ID: 29025584
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
[TBL] [Abstract][Full Text] [Related]
11. Aberrant alternative splicing in breast cancer.
Yang Q; Zhao J; Zhang W; Chen D; Wang Y
J Mol Cell Biol; 2019 Oct; 11(10):920-929. PubMed ID: 31065692
[TBL] [Abstract][Full Text] [Related]
12. The understanding of circular RNAs as special triggers in carcinogenesis.
Xin Z; Ma Q; Ren S; Wang G; Li F
Brief Funct Genomics; 2017 Mar; 16(2):80-86. PubMed ID: 26874353
[TBL] [Abstract][Full Text] [Related]
13. From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform.
Tian N; Li J; Shi J; Sui G
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28257090
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing and cancer: a systematic review.
Zhang Y; Qian J; Gu C; Yang Y
Signal Transduct Target Ther; 2021 Feb; 6(1):78. PubMed ID: 33623018
[TBL] [Abstract][Full Text] [Related]
15. Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy.
Mehterov N; Kazakova M; Sbirkov Y; Vladimirov B; Belev N; Yaneva G; Todorova K; Hayrabedyan S; Sarafian V
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356101
[TBL] [Abstract][Full Text] [Related]
16. Splicing regulation by long noncoding RNAs.
Romero-Barrios N; Legascue MF; Benhamed M; Ariel F; Crespi M
Nucleic Acids Res; 2018 Mar; 46(5):2169-2184. PubMed ID: 29425321
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of splicing in cancer.
Lee SC; Abdel-Wahab O
Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
[TBL] [Abstract][Full Text] [Related]
18. The alternative splicing side of cancer.
Biamonti G; Catillo M; Pignataro D; Montecucco A; Ghigna C
Semin Cell Dev Biol; 2014 Aug; 32():30-6. PubMed ID: 24657195
[TBL] [Abstract][Full Text] [Related]
19. New discoveries of old SON: a link between RNA splicing and cancer.
Hickey CJ; Kim JH; Ahn EY
J Cell Biochem; 2014 Feb; 115(2):224-31. PubMed ID: 24030980
[TBL] [Abstract][Full Text] [Related]
20. Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets.
Zhang L; Liu X; Zhang X; Chen R
Mol Genet Genomics; 2016 Jun; 291(3):1035-51. PubMed ID: 26711644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
